VCEL Insider Trading

Insider Ownership Percentage: 7.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,696,778.29

Vericel Insider Trading History Chart

This chart shows the insider buying and selling history at Vericel by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.04MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Vericel Share Price & Price History

Current Price: $41.23
Price Change: Price Increase of +0.41 (1.00%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for VCEL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$41.23Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for Vericel (NASDAQ:VCEL)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VCEL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$6.75Mbought$460ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
Vericel logo
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Read More on Vericel

Today's Range

Now: $41.23
Low: $40.56
High: $41.59

50 Day Range

MA: $47.75
Low: $38.60
High: $57.78

52 Week Range

Now: $41.23
Low: $37.76
High: $63.00

Volume

343,268 shs

Average Volume

391,695 shs

Market Capitalization

$2.07 billion

P/E Ratio

687.28

Dividend Yield

N/A

Beta

1.61

Who are the company insiders with the largest holdings of Vericel?

Vericel's top insider investors include:
  1. Dominick Colangelo (CEO)
  2. Jonathan Mark Hopper (Insider)
  3. Robert L Md Zerbe (Director)
  4. Paul K Wotton (Director)
  5. Joseph Anthony Mara Jr (CFO)
  6. Steven C Gilman (Director)
  7. Jonathan Siegal (Insider)
  8. Michael Halpin (COO)
  9. Sean C Flynn (Insider)
  10. Sean C Flynn (SVP)
Learn More about top insider investors at Vericel.

Who are the major institutional investors of Vericel?

Vericel's top institutional investors include:
  1. Conestoga Capital Advisors LLC — 4.11%
  2. Congress Asset Management Co. — 2.95%
  3. Rhumbline Advisers — 0.28%
  4. GAMMA Investing LLC — 0.26%
  5. Handelsbanken Fonder AB — 0.04%
  6. Yousif Capital Management LLC — 0.04%
Learn More about top institutional investors of Vericel stock.

Which major investors are selling Vericel stock?

Within the previous quarter, VCEL stock was sold by these institutional investors:
  1. Conestoga Capital Advisors LLC
  2. Juncture Wealth Strategies LLC
  3. Sentry Investment Management LLC
  4. Yousif Capital Management LLC
  5. Summit Global Investments
  6. Rhumbline Advisers
In the last year, company insiders that have sold Vericel company stock include:
  1. Dominick Colangelo (CEO)
  2. Jonathan Mark Hopper (Insider)
  3. Robert L Md Zerbe (Director)
  4. Paul K Wotton (Director)
  5. Joseph Anthony Mara Jr (CFO)
  6. Steven C Gilman (Director)
  7. Jonathan Siegal (Insider)
  8. Michael Halpin (COO)
Learn More investors selling Vericel stock.

Which major investors are buying Vericel stock?

In the last quarter, VCEL stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Congress Asset Management Co.
  3. Portside Wealth Group LLC
  4. Handelsbanken Fonder AB
  5. SG Americas Securities LLC
  6. GAMMA Investing LLC
  7. Portside Wealth Group LLC